Search - tctmd.com

Displaying 41 - 60 of 344

Sort: Relevancy | Date

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

Presenter: Zahid Amin, Jacqueline Saw, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk

October 31, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

Case #4: ASD Closure in an Elderly Patient

Presenter: Ziyad M. Hijazi, Damien P. Kenny, Matthew A Crystal

October 30, 2016

Presentation TCT 2016

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Presenter: Horst Sievert

October 30, 2016

Presentation TCT 2016

PFO Closure: Rationale, Patient Selection and Outcomes

Presenter: Sarah Clarke, Megan M Kennison

October 30, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

FDA 批准 PFO 封堵器用于预防中风复发

Yael L. Maxwell

October 28, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Daily News

Amid Sparse Data on Infection After ASD Closure, Experts Urge Focus on Dental Health

Yael L. Maxwell

September 26, 2016

News Daily News

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Shelley Wood

July 27, 2016

News Daily News

Proposed Legislation Could Mandate Physician Reporting of Adverse Events With Medical Devices

Yael L. Maxwell

June 14, 2016

Presentation SOLACI 2016

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

Presenter: Carlos AC Pedra

June 09, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

Advertisement

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Case #4: ASD Closure in an Elderly Patient

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

PFO Closure: Rationale, Patient Selection and Outcomes

FDA 批准 PFO 封堵器用于预防中风复发

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Amid Sparse Data on Infection After ASD Closure, Experts Urge Focus on Dental Health

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Proposed Legislation Could Mandate Physician Reporting of Adverse Events With Medical Devices

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

TCTMD’s Top 10 Most Popular Stories for May 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content